CreditReports.dk
HomeScreen companies

Salient Pharma ApS Financials, key figures and credit report

CVR number: 36900709 Established 2015 Industry: 46 Wholesale trade
Company contact details
Naverland 22, 2600 Glostrup us@salientpharma.com tel: 42806300 www.salientpharma.com
Gross profit - 129.9 kDKK FY 2025 -4.4% vs 2024
EBIT - 129.9 kDKK FY 2025 -4.4% vs 2024
Net debt 1 306.4 kDKK FY 2025 +27.7% vs 2024
Quick ratio 0.0 FY 2025 +0 vs 2024

Income statement (kDKK)

2021
2022
2023
2024
2025
Fiscal period length1212121212
Net sales
Gross profit- 261.31- 125.51- 233.31- 124.37- 129.89
EBIT- 261.31- 125.51- 233.31- 124.37- 129.89
Other financial expenses-39.95-62.65-71.62-77.81-88.46
Pre-tax profit- 301.26- 188.16- 304.93- 202.18- 218.34
Net earnings- 301.26- 188.16- 304.93- 202.18- 218.34

Assets (kDKK)

2021
2022
2023
2024
2025
Intangible assets total
Tangible assets total
Investments total
Long term receivables total
Raw materials and consumables12.6512.65
Finished products/goods12.1611.46
Inventories total12.1611.4612.6512.65
Current trade debtors3.46
Current other receivables17.8117.5912.28-11.5621.61
Short term receivables total17.8117.5915.73-11.5621.61
Cash and bank deposits24.9328.964.8917.9410.27
Cash and cash equivalents24.9328.964.8917.9410.27
Balance sheet total (assets)54.9058.0120.6219.0244.53

Equity and liabilities (kDKK)

2021
2022
2023
2024
2025
Share capital57.1257.12182.66419.92419.92
Retained earnings- 549.06- 850.32-1 038.48-1 343.40-1 545.59
Profit of the financial year- 301.26- 188.16- 304.93- 202.18- 218.34
Shareholders equity total- 793.20- 981.37-1 160.74-1 125.66-1 344.01
Non-current liabilities total
Advances received3.413.41
Current trade creditors162.55147.02217.62100.4468.44
Current owed to participating680.09892.36963.741 040.841 316.69
Other non-interest bearing current liabilities5.46
Current liabilities total848.101 039.371 181.371 144.691 388.54
Balance sheet total (liabilities)54.9058.0120.6219.0244.53
Page generated